Continuing Education Hub
Select an event to take CE/CME tests, complete evaluations, and download your credit certificates.
Eyes On Glaucoma 2024
Join us at the forefront of glaucoma care and innovation by attending one of the year's most anticipated virtual gatherings, Eyes On Glaucoma 2024. With over 2,000 optometrists (ODs), ophthalmologists (MDs), and glaucoma specialists converging online, this event promises to be an unparalleled opportunity for learning, networking, and showcasing the latest in glaucoma treatment and management. This event will feature 5 COPE-accredited sessions and allow attendees to earn up to 4 credits of CE with sessions focusing on therapeutic and surgical frontiers in glaucoma, glaucoma coding, MIGS, optometric glaucoma management, glaucoma diagnostics, and so much more!
Claim Credit
Eyes On Dry Eye 2024
Discover the future of dry eye solutions by attending the world's largest virtual dry eye event. Step into a groundbreaking virtual gathering designed for optometrists, ophthalmologists, technicians, and industry professionals passionate about advancing in the field of dry eye management. With over 3,500 like-minded experts and peers from around the globe, this unparalleled event offers you a unique opportunity to explore the latest innovations in diagnostics, treatments, and patient care strategies.
Claim Credit
Eyes On 2024
Grow your skills and get ahead of trends at Eyes On 2024—the last and largest virtual eyecare event of the year. Join world-class eyecare physicians for free, COPE-approved CE, attend compelling education on the latest clinical and practice management insights, explore an Innovation Zone bursting with brand-new diagnostics and treatments, and get deals on supplies for your practice that are only available at Eyes On 2024.
Claim Credit
Eyes On Retina 2023
Learn game-changing innovations and insights in the diagnosis and management of vitreoretinal diseases and conditions, including age-related macular degeneration (AMD), diabetic retinopathy, ocular imaging, surgical technologies, ocular inflammation, gene therapy, ocular oncology, and the implementation of treatment modalities.
Claim Credit